Skip to content

Examination of the quantitative relationship between thyroid hormone (freeT4) and thyroid stimulating hormone (TSH) in amniotic fluid and umbilical cord blood

Examination of the quantitative relationship between thyroid hormone (freeT4) and thyroid stimulating hormone (TSH) in amniotic fluid and umbilical cord blood - Examination of the quantitative relationship between thyroid hormone (freeT4) and thyroid stimulating hormone (TSH) in amniotic fluid and umbilical cord blood

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000037988
Enrollment
100
Registered
2019-09-11
Start date
2019-09-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

a pregnant woman

Interventions

None listed

Sponsors

Thyroid Center, Showa University Northern Yokohama Hospital
Lead Sponsor
Roche Diagnostics K.K.
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1) Singleton pregnancy. 2) A pregnant woman undergoing selective cesarean section for obstetrics and gynecology at the Department of Obstetrics and Gynecology, Showa University Northern Yokohama Hospital. 3) Pregnant women who are over 20 years old when obtaining consent. 4) Pregnant women whose consent was obtained in writing

Exclusion criteria

Exclusion criteria: 1) Multiple pregnancy. (In the case of multiple fetuses, there is a possibility that the amniotic fluid between fetuses may be mixed) 2) When there is a lot of bleeding in the hysterotomy wound and there is a high possibility that maternal blood and amniotic fluid are mixed. 3) If a rupture occurs simultaneously with a hysterotomy. 4) When it is difficult to collect amniotic fluid due to lack of amniotic fluid, etc. 5) When it seems difficult to collect umbilical cord blood for reasons such as umbilical cord disconnection. 6) A pregnant woman who has undergone a test using a contrast medium within half a year of pregnancy. 7) Pregnant women who have been diagnosed with fetal heartbeat abnormalities or fetal growth failure on examination before cesarean section. 8) A pregnant woman with a malignant tumor. 9) Pregnant women suffering from serious liver / kidney disorders or heart disease that may affect drug safety assessment. 10) When it is judged that the mother and child are in a dangerous situation. 11) A pregnant woman who is judged to be ineligible at the discretion of the research doctor.

Design outcomes

Primary

MeasureTime frame
Correlation between freeT4 and TSH in amniotic fluid and umbilical cord blood

Secondary

MeasureTime frame
Normal values of amniotic fluid freeT4 and TSH

Countries

Japan

Contacts

Public ContactMitsuhiro Fukushima

Showa University Northern Yokohama Hospital Thyroid Center

fukushima-m@med.showa-u.ac.jp0459497000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026